POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Monday, the 7th day of August, 2023 inter-alia to consider the following: To consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30 June, 2023 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window, the Trading Window for dealing in securities of the Company shall remain closed till 9th August, 2023.